» Articles » PMID: 1764378

Nucleolar Organiser Regions (AgNORs) As Predictors in Transitional Cell Bladder Cancer

Overview
Journal Br J Cancer
Specialty Oncology
Date 1991 Dec 1
PMID 1764378
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The predictive value of silver stained nucleolar organiser regions (AgNORs) was assessed in 229 patients with transitional cell bladder cancer followed up for over 10 years. The AgNORs were enumerated in pretreatment biopsy specimens. The AgNORs were related to clinical stage (T) (P = 0.0111), papillarity (P less than 0.0001), WHO grade (P less than 0.0001), DNA ploidy (P = 0.0010) and S-phase fraction (P less than 0.0001). Tumours presenting with pelvic lymph node involvement (P = 0.0085) or metastasis (P = 0.0780) at the time of diagnosis had more AgNORs than tumours confined to the bladder wall. Progression in T-, N- and M-categories (P = 0.0010-0.0030) was related to AgNORs and consequently they predicted bladder cancer related survival (P = 0.0005). The diploid tumours could be regrouped according to survival by AgNORs (P = 0.0001). In papillary tumours AgNORs predicted progression (P = 0.0110) and survival (P = 0.0038). In Ta-T1 tumours AgNORs predicted progression (P = 0.11) and survival (P = 0.0751) and also in T2-T3 tumours AgNORs contributed to survival significantly (P = 0.0039). The AgNORs subdivided WHO grade III tumours according to their ability to progress during the follow-up time (P = 0.0711). In a multivariate analysis AgNORs predicted progression independently in Ta-T1 category (P = 0.0165). AgNORs predicted recurrence free period like SPF (P = 0.0010). In conclusion, AgNORs are inferior to classic prognostic factors or DNA flow cytometric variables in muscle invasive bladder cancers whereas they have independent predictive value in superficial cancers.

Citing Articles

AgNOR patterns and configurations in adult acute leukemia patients.

Gajewska M, Kwiecien I, Rutkowska E, Rzepecki P, Sulek K Cent Eur J Immunol. 2023; 47(4):323-331.

PMID: 36817394 PMC: 9901258. DOI: 10.5114/ceji.2022.124252.


Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Acute Leukemia in Adults.

Gajewska M, Rutkowska E, Kwiecien I, Rzepecki P, Sulek K Diagnostics (Basel). 2022; 12(4).

PMID: 35453880 PMC: 9027282. DOI: 10.3390/diagnostics12040832.


Nucleolar adaptation in human cancer.

Maggi Jr L, Weber J Cancer Invest. 2005; 23(7):599-608.

PMID: 16305988 PMC: 1403297. DOI: 10.1080/07357900500283085.


Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.

Korneyev I, Mamaev N, Kozlov V, Rybakova M, Al-Shukri S Mol Pathol. 2000; 53(3):129-32.

PMID: 10897331 PMC: 1186918. DOI: 10.1136/mp.53.3.129.


Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder.

Chen G, Lin M, Li R Urol Res. 1997; 25(1):25-30.

PMID: 9079742 DOI: 10.1007/BF00941902.


References
1.
Mansour P, Crocker J, Newman J . Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder. Arch Pathol Lab Med. 1990; 114(12):1261. View

2.
Lee E, Desu M . A computer program for comparing K samples with right-censored data. Comput Programs Biomed. 1972; 2(4):315-21. DOI: 10.1016/0010-468x(72)90019-0. View

3.
Eskelinen M, Lipponen P, Collan Y, Syrjanen K . The role of nucleolar organiser regions as prognostic factors in breast cancer. Eur J Cancer. 1991; 27(8):989-92. DOI: 10.1016/0277-5379(91)90265-f. View

4.
Lipponen P, Eskelinen M, Nordling S . Relationship between DNA flow cytometric data, nuclear morphometric variables and volume-corrected mitotic index in transitional cell bladder tumors. Eur Urol. 1991; 19(4):327-31. DOI: 10.1159/000473653. View

5.
Lipponen P, Eskelinen M . Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosis. Anticancer Res. 1991; 11(1):75-80. View